Anti-LINGO-1 Clinical Trial Failure: A Perspective MStranslate June 23, 2016 Opinion As you may have heard, Biogen recently reported the results of their Phase 2 SYNERGY study. This study tested the efficacy of their monoclonal antibody, opicinumab (anti-LINGO-1), as a remyelination therapy...
